Amgen Inc Stock Three Year Return
AMG Stock | EUR 287.65 0.80 0.28% |
Amgen Inc fundamentals help investors to digest information that contributes to Amgen's financial success or failures. It also enables traders to predict the movement of Amgen Stock. The fundamental analysis module provides a way to measure Amgen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amgen stock.
Amgen |
Amgen Inc Company Three Year Return Analysis
Amgen's Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
More About Three Year Return | All Equity Analysis
Three Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Three Year Fund Return indicator can give a sense of overall fund mid-term potential, it is recommended to compare fund performances against other similar funds, ETFs, or market benchmarks for the same 3 year interval.
Competition |
Based on the latest financial disclosure, Amgen Inc has a Three Year Return of 0.0%. This indicator is about the same for the Other average (which is currently at 0.0) sector and about the same as Other (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
All Next | Launch Module |
Amgen Fundamentals
Current Valuation | 163.09 B | |||
Price To Book | 38.53 X | |||
Price To Sales | 5.48 X | |||
Revenue | 26.32 B | |||
EBITDA | 12.17 B | |||
Net Income | 6.55 B | |||
Total Debt | 37.35 B | |||
Cash Flow From Operations | 9.72 B | |||
Price To Earnings To Growth | 1.51 X | |||
Market Capitalization | 105.18 B | |||
Total Asset | 65.12 B | |||
Z Score | 1.2 | |||
Annual Yield | 0.02 % | |||
Net Asset | 65.12 B | |||
Last Dividend Paid | 1.45 |
About Amgen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amgen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amgen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amgen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Amgen Stock Analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.